Reported 396,768 shares, up 69,327 (21.2%) from the prior quarter.
Reported value 38.3%; share count 21.2% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 5727000 |
| 2022-03-31 | 7923000 |
| 2022-06-30 | 6947000 |
| 2022-09-30 | 27847000 |
| 2022-12-31 | 20424199 |
| 2023-03-31 | 3251272 |
| 2023-06-30 | 1369947 |
| 2023-09-30 | 867940 |
| 2023-12-31 | 1210626 |
| 2024-03-31 | 2209550 |
| 2024-06-30 | 296233 |
| 2024-09-30 | 330798 |
| 2024-12-31 | 237538 |
| 2025-03-31 | 186425 |
| 2025-06-30 | 150622 |
| 2025-09-30 | 197840 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -244,186 (-100.0%) | 0 | $0 | 2026-02-13 | |
| Q3 2025 | Reduced | 244,186 | -2,735 (-1.1%) | < 0.01% | $197,840 | 2025-11-14 | |
| Q2 2025 | Unchanged | 246,921 | 0 (0.0%) | < 0.01% | $150,622 | 2025-08-14 | |
| Q1 2025 | Unchanged | 246,921 | 0 (0.0%) | < 0.01% | $186,425 | 2025-05-15 | |
| Q4 2024 | Added | 246,921 | +17,200 (7.5%) | < 0.01% | $237,538 | 2025-02-14 | |
| Q3 2024 | Reduced | 229,721 | -15,100 (-6.2%) | < 0.01% | $330,798 | 2024-11-14 | |
| Q2 2024 | Reduced | 244,821 | -695,413 (-74.0%) | < 0.01% | $296,233 | 2024-08-14 | |
| Q1 2024 | Added | 940,234 | +299,691 (46.8%) | < 0.01% | $2,209,550 | 2024-05-15 | |
| Q4 2023 | Added | 640,543 | +7,010 (1.1%) | < 0.01% | $1,210,626 | 2024-02-14 | |
| Q3 2023 | Added | 633,533 | +69,769 (12.4%) | < 0.01% | $867,940 | 2023-11-14 | |
| Q2 2023 | Reduced | 563,764 | -693 (-0.1%) | < 0.01% | $1,369,947 | 2023-08-14 | |
| Q1 2023 | Reduced | 564,457 | -1,720,129 (-75.3%) | < 0.01% | $3,251,272 | 2023-05-15 | |
| Q4 2022 | Added | 2,284,586 | +326,321 (16.7%) | < 0.01% | $20,424,199 | 2023-02-14 | |
| Q3 2022 | Added | 1,958,265 | +1,482,409 (311.5%) | < 0.01% | $27,847,000 | 2022-11-15 | |
| Q2 2022 | Added | 475,856 | +79,088 (19.9%) | < 0.01% | $6,947,000 | 2022-08-15 | |
| Q1 2022 | Added | 396,768 | +69,327 (21.2%) | < 0.01% | $7,923,000 | 2022-05-16 | |
| Q4 2021 | Added | 327,441 | +31,194 (10.5%) | < 0.01% | $5,727,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
96 managers reported ADICET BIO INC for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Unchanged | 7,447,141 | 0 | 2.44% | $148,719,000 | 7 qtrs |
| Avidity Partners Management LP | Added | 3,120,000 | +85,996 | 1.3% | $62,306,000 | 5 qtrs |
| RTW INVESTMENTS LP | Reduced | 2,989,482 | -34,262 | 1.24% | $59,700,000 | 2 qtrs |
| Abingworth LLP | Unchanged | 2,115,385 | 0 | 11.96% | $42,160,000 | 5 qtrs |
| BlackRock Inc | Added | 1,618,107 | +165,655 | < 0.01% | $32,314,000 | 7 qtrs |
| Polar Capital Holdings Plc | Added | 1,543,670 | +16,397 | 0.14% | $30,827,000 | 2 qtrs |
| COWEN AND COMPANY LLC | New | 1,500,000 | +1,500,000 | 2.88% | $29,955,000 | 1 qtr |
| VANGUARD GROUP INC | Reduced | 1,071,655 | -175,478 | < 0.01% | $21,401,000 | 7 qtrs |
| Cormorant Asset Management LP | Unchanged | 750,000 | 0 | 1.15% | $14,978,000 | 2 qtrs |
| JOHNSON & JOHNSON | Unchanged | 728,944 | 0 | 2.75% | $14,557,000 | 3 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 16, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 371,070
- Shared
- 0
- None
- 25,698
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.